KAPOSIFORM HAEMANGIOENDOTHELIOMA

KAPOSIFORM HAEMANGIOENDOTHELIOMA was reported 3 times

KAPOSIFORM HAEMANGIOENDOTHELIOMA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC] 1 0.0006
1 Epidermal Growth Factor Receptor Antagonist [EPC] 1 0.0000
2 Kinase Inhibitor [EPC] 1 0.0000
3 Platelet Aggregation Inhibitor [EPC] 1 0.0000
4 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000